Cardiovascular Diabetology

Cardiovascular Diabetology

Discipline	Cardiology, diabetology
Language	English
Edited  by	Enrique Fisman Co-Founder and Editor-in-Chief, Francisco Westermeier Deputy Editor
Publication details
History	2002-present
Publisher	BioMed Central
Open access	Yes
License	Creative Commons Attribution
Impact factor	10.6 (2024)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Cardiovasc. Diabetol.
Indexing CODEN (alt  · alt2) · JSTOR (alt) · LCCN (alt) MIAR  · NLM (alt) · Scopus  · W&L
ISSN	1475-2840
OCLC  no.	848273564
Links
Journal homepage Online access

Cardiovascular Diabetology is a peer-reviewed open access medical journal covering the intersection of cardiology and diabetology, meaning the connection between diabetes, metabolic syndrome and cardiovascular diseases. It is published by BioMed Central (a part of Springer Nature since 2008) and was established in 2002, with Enrique Fisman (Tel Aviv University) and Alexander Tenenbaum (Sheba Medical Center) as founding editors-in-chief. Alexander Tenenbaum passed away in 2022.

Scope

Cardiovascular Diabetology considers for publications manuscripts on all aspects of the diabetes/cardiovascular interrelationship, including clinical, genetic, experimental, pharmacological, epidemiological, molecular biology and laboratory research. Seven article types maybe considered for publication: original investigations, reviews, case reports, commentaries, hypotheses, methodology articles and study protocols; most of published papers are original investigations. Articles are published online upon acceptance, rather than in issues. A printed version is periodically distributed in India by Panacea Biotec Ltd.

Abstracting and indexing

The journal is abstracted and indexed in Chemical Abstracts Service (CAS), Citebase, Current Contents, Directory of Open Access Journals (DOAJ), EMBASE, MEDLINE/PubMed, Science Citation Index, SCImago Journal Rank, Scopus and Socolar. ^[1] According to the Journal Citation Reports , the journal has a 2024 impact factor of 10.6, ranking it in the 94.1 JIF percentile (11 out of 191 journals) in the category of "Endocrinology & Metabolism", and in the 94.7 JIF percentile (14 out of 230 journals) in the category "Cardiac & Cardiovascular Systems" journals. ^[2]

References

1. "About". BioMed Central. Retrieved 16 October 2020.
2. "Cardiovascular Diabetology". 2025 Journal Citation Reports . Web of Science (Science ed.). Clarivate Analytics. 2024.

External links

• Official website